Journal articles on the topic 'Post-marketing'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Post-marketing.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Kretek, Henryk A., and Janusz Dworak. "Post-Pandemic Marketing @Marketing." Multidisciplinary Aspects of Production Engineering 3, no. 1 (September 1, 2020): 584–95. http://dx.doi.org/10.2478/mape-2020-0049.
Full textCruz-Gómez, Omar, and Ana Yuridia Morales-Flores. "Marketing post-pandemia." Ciencia Huasteca Boletín Científico de la Escuela Superior de Huejutla 9, no. 18 (July 5, 2021): 41–42. http://dx.doi.org/10.29057/esh.v9i18.7148.
Full textMackay, Fiona Jean. "Post-Marketing Studies." Drug Safety 19, no. 5 (1998): 343–53. http://dx.doi.org/10.2165/00002018-199819050-00002.
Full textBennett, Suzanne. "Marketing, post-meltdown." Construction Research and Innovation 3, no. 3 (September 2012): 6–7. http://dx.doi.org/10.1080/20450249.2012.11873841.
Full textBöttiger, L. E. "Post Marketing Surveillance." Acta Medica Scandinavica 222, no. 5 (April 24, 2009): 385–87. http://dx.doi.org/10.1111/j.0954-6820.1987.tb10954.x.
Full textSomberg, John. "Mandatory Post Marketing Studies." American Journal of Therapeutics 14, no. 4 (July 2007): 321. http://dx.doi.org/10.1097/mjt.0b013e3181468e21.
Full textRobson, RH. "Post-marketing surveillance [letter]." British Journal of Clinical Pharmacology 25, no. 3 (March 1988): 404–0. http://dx.doi.org/10.1111/j.1365-2125.1988.tb03322.x.
Full textWood, A. J. "Post marketing surveillance studies." Psychiatric Bulletin 18, no. 7 (July 1994): 430. http://dx.doi.org/10.1192/pb.18.7.430-b.
Full textKlein, Donald F. "FDA Post-Marketing Safety Decisions." Journal of Clinical Psychiatry 67, no. 08 (August 15, 2006): 1305–6. http://dx.doi.org/10.4088/jcp.v67n0820.
Full textFeldman, Neil T. "Sodium Oxybate Post-Marketing Surveillance." Journal of Clinical Sleep Medicine 07, no. 04 (August 15, 2011): 417. http://dx.doi.org/10.5664/jcsm.1216.
Full textBell, Kerry D. "Post‐marketing surveillance of drugs." Medical Journal of Australia 154, no. 8 (April 1991): 567. http://dx.doi.org/10.5694/j.1326-5377.1991.tb119466.x.
Full textRoeser, H. Peter, and Alain P. Rohan. "Post‐marketing surveillance of drugs." Medical Journal of Australia 154, no. 8 (April 1991): 567. http://dx.doi.org/10.5694/j.1326-5377.1991.tb119467.x.
Full textXoxi, Entela, Carlo Tomino, Luca de Nigro, and Luca Pani. "The Italian post-marketing registries." Pharmaceutical Programming 5, no. 1-2 (December 2012): 57–60. http://dx.doi.org/10.1179/1757092112z.0000000009.
Full textLewis, J. A., and C. Chilvers. "Post-Marketing Monitoring of Drugs." Journal of the Royal Society of Medicine 78, no. 10 (October 1985): 874–77. http://dx.doi.org/10.1177/014107688507801022.
Full text&NA;. "Improvements for Post-Marketing Surveillance." Emergency Medicine News 27, no. 12 (December 2005): 19. http://dx.doi.org/10.1097/00132981-200512000-00016.
Full textToumi, Mondher. "Post-marketing surveillance of sertindole." International Journal of Psychiatry in Clinical Practice 6, no. 1 (January 2002): 33–35. http://dx.doi.org/10.1080/13651500215968.
Full textClark-Nieuwland, K., F. Dehaen, and O. Teirlynck. "Post-marketing drug safety monitoring." Health Policy 11, no. 3 (June 1989): 239–41. http://dx.doi.org/10.1016/0168-8510(89)90004-3.
Full textVidi, Venkatesan D., Michael E. Matheny, and Frederic S. Resnic. "Post-marketing device safety surveillance." Contemporary Clinical Trials 32, no. 3 (May 2011): 307–8. http://dx.doi.org/10.1016/j.cct.2011.02.002.
Full textBreckenridge, A. "Post-marketing Strategies for Medicines." Clinical Pharmacology & Therapeutics 83, no. 1 (November 28, 2007): 24–25. http://dx.doi.org/10.1038/sj.clpt.6100427.
Full textNaidoo, KK, P. Nompuku, SN Mkalali, K. Shabangu, L. Nkabinde, and V. Singh. "Post-marketing stability surveillance: Amoxicillin." South African Family Practice 48, no. 6 (July 2006): 14–14. http://dx.doi.org/10.1080/20786204.2006.10873401.
Full textRay, Rajat, Hemraj Pal, Rajesh Kumar, Pallab Maulick, and R. Mangla. "Post-marketing surveillance of buprenorphine." Pharmacoepidemiology and Drug Safety 13, no. 9 (September 2004): 615–19. http://dx.doi.org/10.1002/pds.975.
Full textKanmuri, Kazuhiro, and Mamoru Narukawa. "Characteristics of Post-Marketing Studies and their Contribution to Post-Marketing Safety Measures in Japan." Pharmaceutical Medicine 28, no. 2 (February 12, 2014): 67–73. http://dx.doi.org/10.1007/s40290-014-0046-6.
Full textVarey, Richard J. "Editorial: The post-industrial/post-capitalist citizen and marketing." Journal of Customer Behaviour 9, no. 4 (December 6, 2010): 317–19. http://dx.doi.org/10.1362/147539210x543529.
Full textMoylan, Cynthia A., Ayako Suzuki, Julie I. Papay, Nancy A. Yuen, Michael Ames, and Christine M. Hunt. "A pre-marketing ALT signal predicts post-marketing liver safety." Regulatory Toxicology and Pharmacology 63, no. 3 (August 2012): 433–39. http://dx.doi.org/10.1016/j.yrtph.2012.05.016.
Full textRies, Hedy M., Gary B. Weiss, and William J. Winslade. "FDA Requirements and Post-Marketing Studies." IRB: Ethics and Human Research 9, no. 6 (November 1987): 11. http://dx.doi.org/10.2307/3563625.
Full textWarner, J. O. "Post-marketing surveillance of novel foods." Pediatric Allergy and Immunology 13, no. 6 (December 2002): 385. http://dx.doi.org/10.1034/j.1399-3038.2002.t01-1-00136.x.
Full textMurray, J. Alex. "Post-Marketing Surveillance in Pharmaceuticals: Reactions." Journal of Public Policy & Marketing 5, no. 1 (January 1986): 44–60. http://dx.doi.org/10.1177/074391568600500103.
Full textSANO, SHUICHI. "Future problems of post-marketing study." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 26, no. 1 (1995): 395–96. http://dx.doi.org/10.3999/jscpt.26.395.
Full textKadirov, Djavlonbek, and Richard J. Varey. "Towards post-industrial marketing: marketplace wisdom." Journal of Customer Behaviour 9, no. 4 (December 6, 2010): 379–98. http://dx.doi.org/10.1362/147539210x543574.
Full textKumano, Shinsaku. "GPSP: Good Post-Marketing Study Practice." Folia Pharmacologica Japonica 140, no. 2 (2012): 81–84. http://dx.doi.org/10.1254/fpj.140.81.
Full textInman, W., and G. Pearce. "Prescriber profile and post-marketing surveillance." Lancet 342, no. 8872 (September 1993): 658–61. http://dx.doi.org/10.1016/0140-6736(93)91763-c.
Full textJacob, Ian. "‘Sales Promotion in Post Modern Marketing’." Journal of Brand Management 3, no. 2 (October 1995): 132–33. http://dx.doi.org/10.1057/bm.1995.38.
Full textLarance, Briony, Louisa Degenhardt, Richard Mattick, Robert Ali, and Nicholas Lintzeris. "Australian post-marketing surveillance studies, 2012." Drug and Alcohol Dependence 140 (July 2014): e115-e116. http://dx.doi.org/10.1016/j.drugalcdep.2014.02.331.
Full textMarley, J. "Post marketing surveillance of captopril [letter]." British Journal of Clinical Pharmacology 25, no. 6 (June 1988): 781–83. http://dx.doi.org/10.1111/j.1365-2125.1988.tb05272.x.
Full textElias, Rawad, Anita Pudusseri, Oladimeji Akinboro, Paul S. White, and Shayna Sarosiek. "Ibrutinib: A post-marketing safety analysis." Journal of Clinical Oncology 36, no. 15_suppl (May 20, 2018): e19559-e19559. http://dx.doi.org/10.1200/jco.2018.36.15_suppl.e19559.
Full textAlberman, Eva. "Post-marketing surveillance of oral contraceptives*." Human Reproduction 1, no. 7 (November 1986): 433–34. http://dx.doi.org/10.1093/oxfordjournals.humrep.a136448.
Full text&NA;. "Post-marketing surveillance of levofloxacin checks out." Reactions Weekly &NA;, no. 1149 (April 2007): 4. http://dx.doi.org/10.2165/00128415-200711490-00010.
Full textFURUKAWA, Hiroyuki, Keiko KANAYA, Takeshi YAMAZAKI, Toshiharu TAKAGI, Toshiko MASUE, Junko ISHIZAKI, Kazuko KIMURA, and Ken'ichi MIYAMOTO. "Effective Method for Immediate Post-Marketing Surveillance." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 33, no. 6 (2002): 287–94. http://dx.doi.org/10.3999/jscpt.33.6_287.
Full textGersner, Roman, Zach Leber, and Aron Tendler. "Post-marketing analysis of Motor Threshold variability." Brain Stimulation 14, no. 5 (September 2021): 1413. http://dx.doi.org/10.1016/j.brs.2021.07.050.
Full textKalle, Parminder. "Optimization of the post-marketing surveillance procedure." Annales de biologie clinique 75, no. 2 (March 2017): 125–27. http://dx.doi.org/10.1684/abc.2017.1231.
Full text&NA;. "AMA Urges Improvements for Post-Marketing Surveillance." Oncology Times 27, no. 22 (November 2005): 48. http://dx.doi.org/10.1097/01.cot.0000291177.51196.8a.
Full textMELLINGER, GLEN D., MITCHELL B. BALTER, STEPHEN ABRAMOWITZ, CHARLES B. SCHAFFER, and LINDA R. BERNSTEIN. "Survey Method for Post-Marketing Drug Surveillance." Journal of Clinical Psychopharmacology 8, no. 3 (June 1988): 168???176. http://dx.doi.org/10.1097/00004714-198806000-00003.
Full textPottorff, Susan M., and Dr David M. Neal. "Marketing Implications for Post-Disaster Tourism Destinations." Journal of Travel & Tourism Marketing 3, no. 1 (April 4, 1994): 115–22. http://dx.doi.org/10.1300/j073v03n01_08.
Full textKadirov, Djavlonbek, and Richard J. Varey. "Future marketing: dialectics of post-industrial development." Journal of Customer Behaviour 9, no. 4 (December 6, 2010): 357–77. http://dx.doi.org/10.1362/147539210x543565.
Full textKitchen, Philip J., and Tony Proctor. "Marketing communications in a post-modern world." Journal of Business Strategy 36, no. 5 (September 21, 2015): 34–42. http://dx.doi.org/10.1108/jbs-06-2014-0070.
Full textFreeman, C. P. "Post-marketing surveillance (Phase IV drug studies)." Psychiatric Bulletin 18, no. 2 (February 1994): 115–16. http://dx.doi.org/10.1192/pb.18.2.115.
Full textDe Rosa, M., A. Covezzoli, M. A. Bosio, and M. Ortali. "It Application for Post Marketing Drug Registries." Value in Health 16, no. 7 (November 2013): A679. http://dx.doi.org/10.1016/j.jval.2013.08.1997.
Full textVan Der Waldt, De la Rey, and Lynnette Serfontein. "Marketing communication in a post apartheid society." Ecquid Novi: African Journalism Studies 14, no. 2 (January 1993): 193–211. http://dx.doi.org/10.1080/02560054.1993.9653103.
Full textDeschamps, D., N. Rivoire, B. Ferrand, W. Rein, and D. Sallière. "Amisulpride in schizophrenia: Post-marketing safety profile." European Psychiatry 13, S4 (1998): 308s. http://dx.doi.org/10.1016/s0924-9338(99)80626-9.
Full textZhou, Xiao-Hua Andrew, and Wei Yang. "Design and analysis of post-marketing research." Chinese Journal of Integrative Medicine 19, no. 7 (July 2013): 488–93. http://dx.doi.org/10.1007/s11655-013-1501-z.
Full text